Estrella Immunopharma, Inc. Common Stock Shares Outstanding

• Estrella Immunopharma, Inc. showed an increase of +3,642.5% in Common Stock Shares Outstanding from 2023 to 2024.
• This data is from Estrella Immunopharma, Inc.'s annual report (Form 10-K), filed with the SEC on September 27, 2024.
• XBRL data for this metric is available from 2021 to 2024 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 6 years of available data (2021 to 2024), Estrella Immunopharma, Inc.'s Common Stock Shares Outstanding has grown by 2,478.8%.
• Historical annual values: Fiscal year 2024: 36.61 million shares | Fiscal year 2023: 978,243 shares | Fiscal year 2022: 1.42 million shares | Fiscal year 2021: 1.42 million shares | Fiscal year 2021: 1.42 million shares | Fiscal year 2021: 1.42 million shares.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026